Tag: Teprotumumab trbw

Tepezza contains the active ingredient teprotumumab-trbw, which is a biologic drug produced from living cells, not a traditional chemically synthesized medication. This medication represents a specialized, targeted approach to therapy, marking a significant departure from older treatments for Thyroid Eye Disease (TED), the condition it is approved to treat. So, what is Tepezza made of and how does its unique composition work?

Tepezza (teprotumumab-trbw) was the first FDA-approved medication specifically for Thyroid Eye Disease in 2020. For many patients, the high cost of this brand-name treatment raises the question: is there a generic for Tepezza?